# Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl

> **NCT05145764** · PHASE2 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 120 (estimated)

## Conditions studied

- Suvorexant
- Placebo
- Opioid Use Disorder

## Interventions

- **DRUG:** Suvorexant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05145764
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-30
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05145764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05145764, "Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05145764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*